Skip to content

Clinical trials

Completed Phase 1 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1 Status: Completed Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20062
20073
20083
20094
20104
20113
20127
20133
20146
20155
20165
20173
20183
20194
20204
20216
20224
20235
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Suven Life Sciences Limited4
Posit Science Corporation3
Eli Lilly and Company2
Mayo Clinic2
Mclean Hospital2
Merck Sharp & Dohme LLC2
University Hospital, Tours2
University of Southern California2
Wake Forest University Health Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction82
Alzheimer Disease29
Dementia8
Schizophrenia5
Memory Disorders4
Cognition Disorders3
Pain3
Brain Neoplasms2
Breast Neoplasms2
HIV Infections2

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.